CAH logo

CARDINAL HEALTH INC

CAHNYSE
πŸ† #241 by market capEarnings Nov 5US Equity
$244.76β–Ό $1.70 (βˆ’0.69%)
πŸŒ™ After hours$245.80β–² 0.42%Regular close Β· extended-hours price shown
πŸ””
Track CAH
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.7%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$56.68B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
14.2%
Healthy
πŸ“ŠGross Margin
3.8%
Thin
πŸ’΅FCF Margin
1.8%
Thin
βš–οΈP/S Ratio
0.2x
Cheap
Otter Score
76
Strong
No chart data available for CAH.

Trading Snapshot

Day Range
$243.49 – $247.14
52-Week Range
$158.70 – $259.21
Volume (shares)
1,102,270
Avg Volume (shares)
β€”
Shares Outstanding
231.6M
Next Earnings
2026-11-05

Fundamentals Snapshot

Annual Revenue
$254.25B
Last Q Revenue
$63.86B
P/E Ratio
34.2
P/S Ratio
0.2x
EPS (TTM)
$7.24
Dividend Yield
0.84%
Dilution (1yr)
+0.0%
CAH logo

CARDINAL HEALTH INC

CAH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$254.2Bβ–² +14.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
3.8%β–² +4.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2.6Bβ–² +14.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$4.5Bβ–² +144.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
237.0Mβ–² +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$5.1Bβ–² +$1.2B YoY
StockOtter Β· stockotter.space

About CARDINAL HEALTH INC

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
76/100
Analyst data unavailable.

Latest News & Updates

Zacks Investment ResearchΒ·1d ago

Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade

Cardinal Health (CAH) reached $246.45 at the closing of the latest trading day, reflecting a -2.02% change compared to its last close.

Seeking AlphaΒ·5d ago

The Dividend Aristocrats Ranked By Quality Scores (October 2026)

I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, high

Zacks Investment ResearchΒ·8d ago

Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.

Zacks Investment ResearchΒ·13d ago

3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge

As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.

Zacks Investment ResearchΒ·15d ago

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment ResearchΒ·15d ago

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and